VERSANT VENTURES
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm invests across the healthcare sector and at all stages of company development, with an emphasis on the discovery and development of novel therapeutics. With $2.3 billion under management and offices in Canada, the U.S. and Europe, Versant has built a team with deep investment, operating, and scientific expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 65 Versant companies have achieved successful acquisitions or IPOs.
VERSANT VENTURES
Social Links:
Industry:
Financial Services Health Care Venture Capital
Founded:
1999-01-01
Status:
Active
Contact:
+1 415 801 8100
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Amazon Google Apps For Business
Similar Organizations
Amadeus Capital Partners
Amadeus Capital Partners caters to the technology sector with seed, early, and later stage venture, and private equity investments.
Battery Ventures
Battery Ventures finances technology sector companies with venture capital, private equity, and debt financing investments.
Redpoint
Redpoint Ventures partners with visionary founders to create new markets or redefine existing ones at the seed, early, and growth stages.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-10 | Vector BioPharma | Versant Ventures investment in Series A - Vector BioPharma | 30 M USD |
| 2022-04-27 | Tempest Therapeutics | Versant Ventures investment in Post-IPO Equity - Tempest Therapeutics | 15 M USD |
| 2022-04-13 | Cimeio Therapeutics | Versant Ventures investment in Series A - Cimeio Therapeutics | 50 M USD |
| 2022-02-09 | Ventus Therapeutics | Versant Ventures investment in Series C - Ventus Therapeutics | 140 M USD |
| 2021-12-02 | CODA Biotherapeutics | Versant Ventures investment in Venture Round - CODA Biotherapeutics | 28 M USD |
| 2021-11-30 | SanReno Therapeutics | Versant Ventures investment in Funding Round - SanReno Therapeutics | 40 M USD |
| 2021-11-19 | ViaLase | Versant Ventures investment in Series A - ViaLase | 27.29 M USD |
| 2021-10-14 | Tentarix Biotherapeutics | Versant Ventures investment in Series A - Tentarix Biotherapeutics | 50 M USD |
| 2021-09-21 | 858 Therapeutics | Versant Ventures investment in Series A - 858 Therapeutics | 60 M USD |
| 2021-09-09 | iECURE | Versant Ventures investment in Series A - iECURE | 50 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-11-13 | Verdant Ventures Announces the Appointment of Tim Redman as Chief Executive Officer |